[18F]Fdg uptake in proximal muscles assessed by pet/ct reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/ dermatomyositis

Rheumatology (United Kingdom)

Volumn 52, Issue 7, 2013, Pages 1271-1278

  Tanaka, ahigeru ^a   Ikeda, Kei ^a   Uchiyama, Katsuhiro ^b   Iwamoto, Taro ^a   Sanayama, Yoshie ^a   Okubo, Ayako ^a   Nakagomi, Daiki ^a   Takahashi, Kentaro ^a   Yokota, Masaya ^a   Suto, Akira ^a   Suzuki, Kotaro ^a   Nakajima, Hiroshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Sannoh Medical Center   (Japan)

Author keywords

Aldolase; Creatine kinase; Dermatomyositis; Manual muscle test; MRI; Muscle biopsy; Polymyositis

Indexed keywords

CREATINE KINASE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DERMATOMYOSITIS; DRUG UPTAKE; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; MUSCLE BIOPSY; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMYOSITIS; PRIORITY JOURNAL; ADULT; AGED; CASE CONTROL STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; FEMALE; MALE; MEDICAL RECORD; METABOLISM; MIDDLE AGED; MULTIMODAL IMAGING; MUSCLE; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; CASE-CONTROL STUDIES; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL RECORDS; MIDDLE AGED; MULTIMODAL IMAGING; MUSCLE STRENGTH; MUSCLES; POLYMYOSITIS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84891686849     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket112     Document Type: Article

References (28)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
2. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
3. O'Hanlon TP, Carrick DM, Arnett FC, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians. Medicine (Baltimore) 2005;84:338-49.
4. Reed AM, Ytterberg SR. Genetic and environmental risk factors for idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002;28:891-916.
5. Dalakas MC. Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies. Nat Clin Pract Rheumatol 2006;2:219-27.
6. Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991;325:1487-98.
7. Fraser DD, Frank JA, Dalakas M, et al. Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 1991;18:1693-700.
8. Fujino H, Kobayashi T, Goto I et al. Magnetic resonance imaging of the muscles in patients with polymyositis and dermatomyositis. Muscle Nerve 1991;14:716-20.
9. Pitt AM, Fleckenstein JL, Greenlee RG, et al. MRI-guided biopsy in inflammatory myopathy: initial results. Magn Reson Imaging 1993;11:1093-9.
10. Tomasova Studynkova J, Charvat F, Jarosova K, et al. The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology 2007;46:1174-9.
11. Tzaribachev N, Well C, Schedel J, et al. Whole-body MRI: a helpful diagnostic tool for juvenile dermatomyositis case report and review of the literature. Rheumatol Int 2009;29: 1511-4.
12. Weckbach S. Whole-body MR imaging for patients with rheumatism. Eur J Radiol 2009;70:431-41.
13. Basu S, Zhuang H, Torigian DA, et al. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med 2009;39:124-45.
14. Stumpe KD, Dazzi H, Schaffner A, et al. Infection imaging using whole-body FDG-PET. Eur J Nucl Med 2000;27: 822-32.
15. Blockmans D, Knockaert D, Maes A et al. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001;32:191-6.
16. Brudin LH, Valind SO, Rhodes CG, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994;21: 297-305.
17. Hooisma GA, Balink H, Houtman PM, et al. Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study. Clin Rheumatol 2012;31:861-71.
18. Meller J, Altenvoerde G, Munzel U, et al. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med 2000;27:1617-25.
19. Okamura K, Yonemoto Y, Arisaka Y, et al. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. Rheumatology 2012;51: 1484-91.
20. Webb M, Al-Nahhas A. Molecular imaging of Takayasu's arteritis and other large-vessel vasculitis with 18F-FDG PET. Nucl Med Commun 2006;27:547-9.
21. Owada T, Maezawa R, Kurasawa K, et al. Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis. J Rheumatol 2012;39: 1659-65.
22. Pipitone N, Versari A, Zuccoli G, et al. 18F-fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series. Clin Exp Rheumatol 2012;30:570-3.
23. Kendall F, McCreary E, Provance P, et al. Muscles: testing and function, 5th edn. Baltimore: Williams & Wilkins, 2005.
24. Harris-Love MO, Shrader JA, Koziol D, et al. Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology 2009;48:134-9.
25. Rider LG, Koziol D, Giannini EH, et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res 2010;62:465-72.
26. Ishimori T, Saga T, Mamede M, et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 2002;43: 658-63.
27. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33: 1972-80.
28. Selva-O'Callaghan A, Grau JM, Gamez-Cenzano C, et al. Conventional cancer screening versus PET/CT in dermatomyositis/polymyositis. Am J Med 2010;123: 558-62.